New syringe production line up and running at BD

Becton Dickinson’s North Canaan plant opened in 1961 with eight employees and a 25,000 square foot facility. Today the operation employs more than 540 people and encompasses 385,000 square feet.

Provided

New syringe production line up and running at BD

NORTH CANAAN — New production lines installed in 2024 at Becton, Dickinson and Company’s Connecticut and Nebraska plants are now pumping out critical medical devices — including syringes, needles and IV catheters — to meet the burgeoning needs of the nation’s health care system.

One syringe production line is already fully operational at the vaccine manufacturer’s 385,000 square foot North Canaan plant, with additional lines expected to start up in the coming months, the leading global medical technology company announced on Jan. 15.

The new production lines will boost BD’s capacity for safety-engineered injection devices by more than 40% and conventional syringes by more than 50%, adding millions of units annually to support hospital procedures, vaccinations, medication preparation and drug delivery to patients, company officials said.

The Connecticut plant manufactures small-size syringes and syringe and needle combination products. Operations take place around the clock and are sold in every region worldwide.

“Domestic manufacturing is crucial for ensuring a resilient supply of essential healthcare devices,” said Eric Borin, president of Medication Delivery Solutions at BD.

“By expanding our production capacity, we are not only meeting the critical needs of patients and providers, but we also are reinforcing our commitment to the nation’s health care infrastructure,” Borin said.

To support this production, the vaccine manufacturer has hired more than 215 full-time employees at its facilities in Nebraska and Connecticut, with more than 145 of those jobs based in North Canaan, boosting that plant’s employee roster to more than 540.

The North Canaan plant, which opened in 1961 with eight employees and a 25,000 square foot facility, is Northwest Connecticut’s largest employer.

In 2024, the company invested more than $10 million to expand its manufacturing capacity at its Connecticut and Nebraska facilities in response to quality issues with plastic syringes imported from China that were uncovered in late 2023 by the U.S. Food and Drug Administration.

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with China-made plastic syringes not cleared by the FDA, and in August 2024 recommended that healthcare providers “use syringes not manufactured in China, if possible.”

At that time, Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, New Jersey-based company, announced that production lines and production staff were being relocated to North Canaan from other BD plants as part of the expansion.

Becton, Dickinson and Company, which operates more than 30 manufacturing and distribution facilities around the country, announced plans last week to invest more than $30 million in 2025 to expand manufacturing capacity for IV lines at its plant in Utah. That facility, said officials, is the largest producer of IV catheter lines in the world.

The company’s Connecticut, Nebraska and Utah plants alone have collectively 200 years of experience in manufacturing critical medical devices, company officials said, and are the only remaining large-scale manufacturing sites in the country.

Latest News

Honoring the past: bearing witness at Auschwitz
Barbed wire at Birkenau.
Natalia Zukerman

Jan. 27 marked the 80th anniversary of the liberation of Auschwitz-Birkenau. I traveled to Poland as part of a delegation for the commemoration and spent a few days before the event with my father and sister learning, remembering and gathering information.

My dad’s parents, Miriam and Yehuda, of blessed memory, were deported to Auschwitz -Birkenau from the Lódz Ghetto. They both had families that perished and met each other after the camp was liberated.

Keep ReadingShow less
Dina La Fonte at Mountainside and the rise of the ‘sober curious’ movement

Dina La Fonte

Photo by Dina La Fonte

The “sober curious” movement has gained momentum in recent years, encouraging individuals to explore life without alcohol—whether for health reasons, personal growth, or simple curiosity. Dina La Fonte, a certified recovery coach, is the Senior Business Affairs Associate at Mountainside, an alcohol and drug addiction treatment center with a holistic approach to wellness that has several locations, including the one in Canaan, Connecticut. With nearly five years of sobriety, La Fonte blends professional expertise with lived experience, making her a powerful advocate for recovery.

Like many, La Fonte’s path to recovery was not just about removing alcohol; it was about rediscovering herself. “Once you get sober from a substance, whether it’s alcohol, drugs, gambling or what have you, emotional aspects of change come into place,” she explained. “It’s not a hard stop; it’s a continued process of integration and struggle.” Her own journey has led her to a career in recovery coaching, allowing her to help others find their own path.

Keep ReadingShow less
Examining Mohawk Mountain’s rich history

James Shay signed copies of his book “Mohawk Mountain Skl Area: The Birth of Snowmaking” after a talk at Hotchkiss Library of Sharon Feb. 2.

Matthew Kreta

The Hotchkiss Library of Sharon hosted local author James Shay Feb. 2 for a talk on his new book “Mohawk Mountain Ski Area: The Birth of Snowmaking.”

The book follows the life of Mohawk founder Walt Schoenknecht and his important contributions to the sport of skiing.

Keep ReadingShow less